Researchers uncovered a mechanism by which regulatory T-cells (Tregs), immune cells that keep the immune system in check and prevent…
Articles by Lindsey Shapiro, PhD
Obesity promotes molecular signatures associated with more inflammation and multiple sclerosis (MS) signaling pathways specifically in females, which may…
About a third of people with relapsing-remitting multiple sclerosis (RRMS) exhibit cognitive impairments, according to a review by Australian…
Multiple sclerosis (MS) patients exhibited greater resistance to the effects of insulin — the hormone responsible for keeping the…
Measures associated with how well individuals can modulate their backward walking speed could be used as a screening tool for…
Researchers have identified characteristics of regulatory T-cells (Tregs) — a family of immune cells that help keep harmful immune reactions…
A three month cognitive rehabilitation program, with or without aerobic exercise, increased tissue volume and activity in brain regions linked…
England’s National Institute for Health and Care Excellence (NICE) has updated its guidance on the use of Mavenclad (cladribine)…
A large clinical trial to test online programs for treating fatigue in people with multiple sclerosis (MS) will…
Resistance training by middle-aged people with multiple sclerosis (MS) was linked with significant improvements in muscle strength in a…
MS Australia released a report highlighting the critical need for faster multiple sclerosis (MS) diagnoses. While diagnostic delays…
Rehabilitation approaches involving virtual reality (VR) may have beneficial effects on cognitive function and anxiety in people with multiple…
Certain biomarkers in the cerebrospinal fluid (CSF) — the fluid surrounding the brain and spinal cord — around the time…
A specialized imaging approach was able to detect signs of persistent inflammation in the brains of people with multiple…
Researchers have identified a distinct profile of self-reactive antibodies that appear in the blood years before the first clinical signs…
Ocrevus (ocrelizumab) continued to prevent disability progression among people with relapsing and progressive forms of multiple sclerosis (MS)…
For people recently diagnosed with multiple sclerosis (MS), first-line treatment with Kesimpta (ofatumumab) was associated with a lower…
Ocrevus (ocrelizumab) had similar benefits in Black and Hispanic multiple sclerosis (MS) patients as earlier clinical trials with…
The Swank and Wahls diets, which are used by people with multiple sclerosis (MS), were associated with improvements in…
Treatment with the neuroprotective protein HB-EGF eased inflammation and promoted tissue recovery across various disease stages in a multiple…
Health Canada has approved the commercial use of ETNA-MS, a software-based medical device that uses eye tracking to noninvasively measure…
Almost all of the nearly 700 people with multiple sclerosis (MS) in Italy who responded to a patient survey…
A subset of astrocytes — a type of support cell for the central nervous system — has a form of immune-related…
People with multiple sclerosis (MS) have a twofold higher risk of seizures compared with the general population, according to…
Using antibodies against a viral protein that’s needed for the Epstein-Barr virus (EBV) to invade human cells was found…
The Polish biotechnology company PolTREG plans to launch Phase 2 trials testing its Tregs therapy — the T-cell-based treatment…
The U.S. Food and Drug Administration (FDA) has decided not to approve an application seeking clearance of GA Depot…
The presence in the brain of chronic inflammatory lesions — called paramagnetic rim lesions (PRLs) — in people with…
Bolstered by Phase 2 trial data showing that frexalimab safely reduces the number of brain lesions in people with relapsing…
An intermittent fasting (IF) diet may lead to immune and metabolic alterations that ease…